InMed Pharmaceuticals Inc INM

Healthcare Cannabis

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

NDAQ:INM - Post by User

InMed Pharmaceuticals Inc

Bullboard Posts

Comment by hlghrideron Jul 31, 2014 10:31am

197 Views

Post# 22798189

RE:THE GW COMPARABLE

This was a bad idea from the start. Nick dumped money in to help support this and now if he sells off his remaining shares it could collapse. Too many CEO's think bigger is better. Stick to one plan and make that company a success then move forward. Families in India have 20 kids and hope one survives but if they only had one they would guarantee the survival of their baby. Is Nick from India? Just curious. I also wonder if his friends and family realize he has gone too far and have stopped supporting his big dream? Maybe his wallet is tapped out too.

Bullboard Posts

TELUS adds 347K customers in Q3